# Eli Lilly and Company (LLY) — Q4-2008 Earnings Results

**Report date:** 2009-01-29 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2008

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down 2.87%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.07 | N/A | +1.81% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future growth. They emphasized their commitment to innovation and navigating market conditions.

**Key quotes:**

> Management highlighted the importance of ongoing product development.

> They expressed confidence in their pipeline despite current market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock fell by 2.87%, likely due to the absence of revenue details and guidance, which left investors uncertain about future performance. The cautious tone from management may also have contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2008_